BCL11A Polymorphism in Egyptian Children with β-Thalassemia: Relation to Phenotypic Heterogeneity
- PMID: 36684548
- PMCID: PMC9848767
- DOI: 10.1055/s-0041-1728744
BCL11A Polymorphism in Egyptian Children with β-Thalassemia: Relation to Phenotypic Heterogeneity
Abstract
Fetal hemoglobin (HbF) is a potent genetic modifier of β-thalassemia phenotype. B-cell lymphoma 11A ( BCL11A ) gene results in significant silencing of HbF. The aim of this study was to assess the prevalence of different BCL11A genotypes among a cohort of Egyptian children with β-thalassemia and to correlate them to HbF and clinical severity score. Eighty-two children with β-thalassemia (aged 12.95 ± 3.63 years) were recruited from the Pediatric Hematology Clinic, Ain Shams University. They were divided based on the clinical severity of β-thalassemia into three subgroups: 20 mild (24.4%), 24 moderate (29.3%), and 38 severe (46.3%). Age, gender, age of diagnosis, initial HbF level, transfusion history, and history of splenectomy were assessed. Anthropometric measures, signs of anemia and hemosiderosis, and the severity score were determined. Laboratory investigations such as complete blood picture, ferritin, and single gene polymorphism genotyping of the rs11886868 were also performed. Our findings showed that 16 children had CC genotype (19.5%), 38 had TC genotype (46.3%), and 28 had TT genotype (34.1%) of the rs#. β-thalassemia children with TT genotype had significantly higher severity scoring than the other two groups ( p < 0.001). Moreover, mean initial HbF was found to be lower in children with TT genotype followed by TC and CC genotypes ( p < 0.001). Increased γ-globin expression associated with BCL11A gene polymorphism is associated with better clinical severity of β-thalassemia.
Keywords: BCL11A polymorphism; phenotypic heterogeneity; β-thalassemia.
Thieme. All rights reserved.
Conflict of interest statement
Conflict of Interest None declared.
Figures

Similar articles
-
Association of BCL11A genetic variant (rs11886868) with severity in β-thalassaemia major & sickle cell anaemia.Indian J Med Res. 2016 Apr;143(4):449-54. doi: 10.4103/0971-5916.184285. Indian J Med Res. 2016. PMID: 27377501 Free PMC article.
-
Modifying effect of XmnI, BCL11A, and HBS1L-MYB on clinical appearances: A study on β-thalassemia and hemoglobin E/β-thalassemia patients in Indonesia.Hematol Oncol Stem Cell Ther. 2016 Jun;9(2):55-63. doi: 10.1016/j.hemonc.2016.02.003. Epub 2016 Mar 17. Hematol Oncol Stem Cell Ther. 2016. PMID: 27009595
-
Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia.Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1620-5. doi: 10.1073/pnas.0711566105. Epub 2008 Feb 1. Proc Natl Acad Sci U S A. 2008. PMID: 18245381 Free PMC article.
-
Using Clustered Regularly Interspaced Short Palindromic Repeats gene editing to induce permanent expression of fetal hemoglobin in β-thalassemia and sickle cell disease: A comparative meta-analysis.Front Med (Lausanne). 2022 Sep 29;9:943631. doi: 10.3389/fmed.2022.943631. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36250099 Free PMC article.
-
Regulation of the fetal hemoglobin silencing factor BCL11A.Ann N Y Acad Sci. 2016 Mar;1368(1):25-30. doi: 10.1111/nyas.13024. Epub 2016 Mar 9. Ann N Y Acad Sci. 2016. PMID: 26963603 Free PMC article. Review.
Cited by
-
Responses of β-thalassemia and compound heterozygote of Sickle/βthalassemia of BCL11A Gene Polymorphism in Pakistani Patients.Pak J Med Sci. 2023 Nov-Dec;39(6):1788-1792. doi: 10.12669/pjms.39.6.7183. Pak J Med Sci. 2023. PMID: 37936787 Free PMC article.
References
-
- Akhtar M S, Qaw F, Borgio J F. Spectrum of α-thalassemia mutations in transfusion-dependent β-thalassemia patients from the Eastern Province of Saudi Arabia. Hemoglobin. 2013;37(01):65–73. - PubMed
-
- Thein S L. Genetic basis and genetic modifiers of β-thalassemia and sickle cell disease. Adv Exp Med Biol. 2017;1013:27–57. - PubMed
-
- Graffeo L, Vitrano A, Giambona A. The heterozygote state for β-thalassemia detrimentally affects health outcomes. Am J Hematol. 2017;92(03):E23–E25. - PubMed
LinkOut - more resources
Full Text Sources